Brief: Austar Lifesciences expects to record an increase in FY loss attributable
24/11/2017 10:07
Nov 24 (Reuters) - Austar Lifesciences Ltd 6118.HK
* Expected to record a substantial increase in loss
attributable
to shareholders of company for year ending 31 december 2017
* Expected result due to increase in selling and marketing
expenses
Source text for Eikon: urn:newsml:reuters.com:*:nHKS5hLKB7
Further company coverage: 6118.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Austar Lifesciences
See all newsAustar Lifesciences H1 profit drops on higher R&D spending
Brief: Austar Lifesciences Expects HY Profit Attributable Of RMB8 Million-RMB10 Million
Brief: Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million
Brief: Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY
Brief: Austar Lifesciences Says Chen Yuewu Resigned As Executive Director